The mucosal atomization device market is projected to grow from USD 570.52 million in 2024 to USD 1.11 billion by 2034, at a CAGR of 6.9%. Growth is driven by the increasing demand for non-invasive ...
By focusing on innovative, long-lasting pain relief methods, Brixton is well-positioned to contribute to the shift away from opioid dependence. The company’s technologies align with the objectives of ...
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) ("Virpax" or the "Company"), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central ...
(Nasdaq: VRPX), a biotechnology firm focused on innovative pain management solutions, has captured the attention of investors with its latest news. In a surprising turn of events, Virpax’s stock price ...
Dr. Mark Rollin Young, accused of sexual misconduct with patients, appeared virtually Thursday in Garfield County District Court, where a prosecutor said a plea offer has been made to the ...